This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. (RESOLVE-AF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05883631
Recruitment Status : Recruiting
First Posted : June 1, 2023
Last Update Posted : February 29, 2024
Information provided by (Responsible Party):
Cortex ( Ablacon, Inc. )

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 31, 2025
Estimated Study Completion Date : March 31, 2025